CAD 0.3
(-4.76%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.04 CAD | 27.7% |
2022 | -0.06 CAD | 55.64% |
2021 | -0.14 CAD | -4900.0% |
2020 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.05 CAD | -296.35% |
2023 Q1 | -0.03 CAD | -62.56% |
2023 FY | - CAD | 27.7% |
2023 Q4 | -0.01 CAD | -9.6% |
2023 Q2 | -0.02 CAD | 37.54% |
2023 Q3 | -0.01 CAD | 36.87% |
2022 Q1 | -0.04 CAD | 58.35% |
2022 Q4 | -0.02 CAD | -66.67% |
2022 Q3 | -0.01 CAD | 55.85% |
2022 FY | - CAD | 55.64% |
2022 Q2 | -0.03 CAD | 31.88% |
2021 Q3 | -0.11 CAD | -166.34% |
2021 Q1 | -0.18 CAD | 0.0% |
2021 Q4 | -0.09 CAD | 15.09% |
2021 FY | - CAD | -4900.0% |
2021 Q2 | -0.04 CAD | 77.06% |
2020 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AI/ML Innovations Inc. | -0.06 CAD | 20.671% |
Diagnamed Holdings Corp. | -0.02 CAD | -175.46% |
Pangenomic Health Inc. | -0.30 CAD | 85.033% |
nDatalyze Corp. | -0.00 CAD | -1022.5% |
Treatment.Com International Inc. | -0.26 CAD | 82.731% |